From genome to immune response

From genome to immune response
© Thinkstock

Being able to predict which peptides are more efficient at generating immune responses would be ideal when designing vaccination approaches. European scientists made this possible by developing state-of-the-art bioinformatics tools.

With the advent of genome , it has become easier to sequence the entire genome of in a short period of time. Such information could be used to study the biology of almost any pathogen and its potential effect – through the translated proteins – to the system.

are among the key processing units of our immune system. T cells have been developed to be able to recognise and bind peptides presented on MHC molecules of antigen-presenting cells or host cells. Peptide generation and presentation is a rather complicated process involving many steps. In essence, each individual presents to their T cells a unique and highly diverse peptide imprint of the ongoing protein metabolism.

The rationale behind the EU-funded ‘Translating genome and proteome information into immune recognition’ (Genomes_TO_Vaccines) project was to understand, describe and predict how the immune system handles proteins.

Efficient biochemical assays were initially developed to be able to evaluate the three major steps in the generation of T cell epitopes. These included the proteolytic fragmentation of protein antigens in the proteasome, the peptide translocation event (TAP), and the peptide selection and presentation on MHC molecules.

Scientists used bioinformatics to predict the outcome of these processes in silico and potential human T cell responses. Influenza A viral isolates were used to test the epitope scanning process, and predict peptides both in biochemical MHC binding assays as well as, more importantly, in healthy influenza convalescents.

Combined with data on the SARS virus, the Genomes_TO_Vaccines study identified 13 new influenza epitopes, which covered virtually the entire population. These epitopes were selected for being highly conserved and, notably, they all encompassed the current bird flu isolates.

Genomes_TO_Vaccines demonstrated the feasibility of translating genomic information into immune recognition. The developed technology has the potential to be utilised for designing immunotherapy and vaccination strategies, thus improving the quality of life for European citizens.

add to favorites email to friend print save as pdf

Related Stories

Modeling pathogen responses

Oct 12, 2007

The search for a vaccination against HIV has been in progress since 1984, with very little success. Traditional methods used for identifying potential cellular targets can be very costly and time-consuming. The key to creating ...

A safer vaccination for Alzheimer's disease?

Oct 11, 2011

The research shows that in addition to the major histocompatibility complex (MHC) molecules, which present the antigen vaccine to the immune cells, genetic factors, that control some immune cells, influence the quality of ...

Discovery prompts new theory on cause of autoimmune diseases

May 03, 2010

The recent discovery of a protein fragment capable of causing diabetes in mice has spurred researchers at National Jewish Health and the University of Colorado Denver to propose a new hypothesis about the cause of diabetes ...

Recommended for you

User comments